Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Stock Price

RGCStock

$5.54−58.67%52W

Market Cap$2.74B

P/E—

PEG Ratio—

Div yield—

Beta1.30

RGC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-94.66%

Price vs S&P 500 (4W)-14.44%

VGM Score14.90

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	F	$5.54
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$44.81
TRLVTrulieve Cannabis Corp.	B	C	A	$11.32
CRONCronos Group Inc. Common Share	C	B	B	$3.51
GLASGlass House Brands Inc.	C	C	C	$10.13
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.88
CGCCanopy Growth Corporation Common Shares	B	C	C	$1.07
SNDLSundial Growers Inc. Common Shares	A	C	C	$1.37
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.27
USNAUSANA Health Sciences Inc	B	D	D	$13.78
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.97
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$10.05
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.58
NAIINatural Alternatives International Inc.	A	C	D	$2.17
MTEXMannatech Inc.	B	D	C	$6.45
BONBon Natural Life Limited Class A Ordinary Shares	B	D	D	$1.14
AKANAkanda Corp. Common Shares	C	F	F	$4.95
IMCCIM Cannabis Corp. Common Shares	A	B	F	$0.11
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	F	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	D	$23.68

About Regencell Bioscience Holdings Limited Ordinary Shares

Regencell Bioscience Holdings Ltd develops and commercializes traditional Chinese medicine (TCM) treatments for neurocognitive and immune-related disorders. The company's pipeline targets attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and infectious diseases affecting immune function.